Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment

被引：28

作者：

Abdi J. ^{[1
,2
]}

Qiu L. ^{[3
]}

Chang H. ^{[1
,2
,3
,4
]}

机构：

[1] Division of Molecular and Cellular Biology, Toronto General Research Institute, Toronto

[2] Department of Laboratory Medicine and Pathobiology, University of Toronto, 172 St George St, Toronto, M5R 0A3, ON

[3] Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin

[4] Department of Laboratory Hematology, Laboratory Medicine Program, Toronto General Hospital University Health Network, 200 Elizabeth Street 11E-413, Toronto, M5G 2C4, ON

来源：

Biomarker Research | / 2卷 / 1期

基金：

中国国家自然科学基金;

关键词：

Bone marrow stroma; CAMDR; miRNA; Multiple myeloma;

D O I：

10.1186/2050-7771-2-10

中图分类号：

学科分类号：

摘要：

The established interaction between multiple myeloma cells and bone marrow microenvironment components provides malignant cells with various survival, growth and drug resistance signals. As a new concept, identification of miRNAs and their related gene/protein targets, signaling molecules and pathways in the context of bone marrow microenvironment will help understanding more deeply the pathogenesis of the disease and possible mechanisms underlying environment-induced drug resistance. Recent studies suggest that bone marrow stromal cells can modulate some miRNAs (miR-21, miR-15a/16) in multiple myeloma cells through direct adhesion, cytokine secretion or transfer of miRNA-containing exosomes, however; the specific miRNA targets are not clear. In spite of a remarkable progress in understanding myeloma biology and therapy, the disease persists to be hard to treat. This review will discuss the most recent findings on miRNAs expression and function in the context of bone marrow microenvironment highlighting the miRNAs as potential therapeutic targets in multiple myeloma. © 2014 Abdi et al.

引用

共 41 条

[1]

Manier S., Sacco A., Leleu X., Ghobrial I.M., Roccaro A.M., Bone marrow microenvironment in multiple myeloma progression, J Biomed Biotechnol, 2012, (2012)

[2]

Gorgun G.T., Whitehill G., Anderson J.L., Hideshima T., Maguire C., Laubach J., Raje N., Munshi N.C., Richardson P.G., Anderson K.C., Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans, Blood, 121, pp. 2975-2987, (2013)

[3]

Tamura H., Ishibashi M., Yamashita T., Tanosaki S., Okuyama N., Kondo A., Hyodo H., Shinya E., Takahashi H., Dong H., Tamada K., Chen L., Dan K., Ogata K., Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma, Leukemia, 27, pp. 464-472, (2013)

[4]

Vallet S., Podar K., New insights, recent advances, and current challenges in the biological treatment of multiple myeloma, Expert Opin Biol Ther, 13, pp. S35-53, (2013)

[5]

Pichiorri F., Suh S.S., Ladetto M., Kuehl M., Palumbo T., Drandi D., Taccioli C., Zanesi N., Alder H., Hagan J.P., Munker R., Volinia S., Boccadoro M., Garzon R., Palumbo A., Aqeilan R.I., Croce C.M., MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis, Proc Natl Acad Sci U S A, 105, pp. 12885-12890, (2008)

[6]

Saha M.N., Jiang H., Yang Y., Reece D., Chang H., PRIMA-1Met/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and Noxa, Mol Cancer Ther, 12, pp. 2331-2341, (2013)

[7]

Jianxiang Chi E.B., Xiao-He C., Rajko K., Steve T., Deborah H., Daniela T., Saunders T.L., Francesco P., Jacqueline B., Wainscoat J.S., Lawrie C.S.H.C.H., MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival, Biol Direct, 6, pp. 1-17, (2011)

[8]

Pichiorri F., Suh S.S., Rocci A., De Luca L., Taccioli C., Santhanam R., Zhou W., Benson D.M., Hofmainster C., Alder H., Garofalo M., Di Leva G., Volinia S., Lin H.J., Perrotti D., Kuehl M., Aqeilan R.I., Palumbo A., Croce C.M., Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development, Cancer Cell, 18, pp. 367-381, (2010)

[9]

Lionetti M., Biasiolo M., Agnelli L., Todoerti K., Mosca L., Fabris S., Sales G., Deliliers G.L., Bicciato S., Lombardi L., Bortoluzzi S., Neri A., Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma, Blood, 114, pp. e20-26, (2009)

[10]

Roccaro A.M., Sacco A., Thompson B., Leleu X., Azab A.K., Azab F., Runnels J., Jia X., Ngo H.T., Melhem M.R., Lin C.P., Ribatti D., Rollins B.J., Witzig T.E., Anderson K.C., Ghobrial I.M., MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma, Blood, 113, pp. 6669-6680, (2009)

← 1 2 3 4 5 →